Report cover image

Orifarm Group AS - Strategic SWOT Analysis Review

Publisher GlobalData
Published Jun 23, 2025
Length 37 Pages
SKU # GBDT20155300

Description

Orifarm Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Orifarm Group A/S (Orifarm) is a healthcare company. It focuses on the manufacturing, commercialization, and trading of pharmaceutical products. The company imports, repackages, and sells medicine; provides off-patent, small molecule medicine; and supplies consumer healthcare products. Orifarm's product portfolio includes pharmaceuticals for primary and secondary care, over-the-counter (OTC) products, and consumer healthcare products. The company supplies its products to wholesalers, pharmacies, hospitals, and patients. It has an operational presence in Europe and the US. Orifarm is headquartered in Odense, Denmark.

Orifarm Group AS Key Recent Developments

May 08,2025: Orifarm Appoints New CEO to Spearhead Growth
Mar 25,2025: Orifarm Delivers Strong Revenue Growth and Announces Change in CEO
Dec 30,2024: Orifarm Group completes strategic investment with Carlyle Global Credit
Nov 18,2024: Inauguration of new office for Orifarm in Stockholm

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

37 Pages
Section 1 - About the Company
Orifarm Group A/S - Key Facts
Orifarm Group A/S - Key Employees
Orifarm Group A/S - Key Employee Biographies
Orifarm Group A/S - Major Products and Services
Orifarm Group A/S - History
Orifarm Group A/S - Company Statement
Orifarm Group A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Orifarm Group A/S - Business Description
Product Category: Consumer Healthcare & Specialty Rx
Performance
Product Category: Other Revenue
Performance
Product Category: Pharma Trade
Performance
Orifarm Group A/S - Corporate Strategy
Orifarm Group A/S - SWOT Analysis
SWOT Analysis - Overview
Orifarm Group A/S - Strengths
Orifarm Group A/S - Weaknesses
Orifarm Group A/S - Opportunities
Orifarm Group A/S - Threats
Orifarm Group A/S - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Orifarm Group A/S, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 08, 2025: Orifarm Appoints New CEO to Spearhead Growth
Mar 25, 2025: Orifarm Delivers Strong Revenue Growth and Announces Change in CEO
Dec 30, 2024: Orifarm Group completes strategic investment with Carlyle Global Credit
Nov 18, 2024: Inauguration of new office for Orifarm in Stockholm
Aug 28, 2024: Orifarm Group Appoints New CFO
May 05, 2024: Orifarm Data Community talks AI and machine-learning
Apr 23, 2024: Orifarm Prepares for Further Growth
Apr 09, 2024: Orifarm launches its own Artificial Intelligence tools
Apr 05, 2024: Orifarm Announces Relocation from Orifarm Denmark to Orifarm Norway
Jan 31, 2024: Orifarm Adjusts Its Operating Model to Become Even More Customer Focused and Agile
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Orifarm Group A/S, Key Facts
Orifarm Group A/S, Key Employees
Orifarm Group A/S, Key Employee Biographies
Orifarm Group A/S, Major Products and Services
Orifarm Group A/S, History
Orifarm Group A/S, Subsidiaries
Orifarm Group A/S, Key Competitors
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Orifarm Group A/S, Recent Deals Summary
List of Figures
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us